Merck & Co Expands Biologics Manufacturing
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 12 (Table of Contents)
Published: 21 Dec-2009
DOI: 10.3833/pdr.v2009.i12.1290 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
As part of its overall strategy to bolster its biologics manufacturing facilities, Merck & Co is to acquire the entire assets and workforce of Avecia Group’s biologics business located at Billingham, UK...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS